F2 and COVID-19: Coronavirus disease 2019 (COVID-19)-associated coagulopathy is characterized by elevated levels of fibrinogen, mildly prolonged or no change in prothrombin time, and decreased or no change in platelet counts (Bonaventura et al., 2021; Loo et al., 2021).